MINIRIN
MINIRIN (desmopressin) is indicated for the treatment of bedwetting in children and nocturia in adults. Both conditions are usually caused by an overproduction of urine at night, and MINIRIN acts on the kidneys to reduce this. Bedwetting can be traumatic for children, affecting their well-being and self-esteem. For adults with nocturia, waking up several times a night to urinate can lead to sleep deprivation affecting a patient’s quality of life.
Why use MINIRIN in bedwetting?
- MINIRIN reduces the amount of urine produced during the night and therefore prevents bedwetting; daily use brings regular dry nights in around 70% of patients
- MINIRIN is available in a child-friendly, fast melting formulation: MINIRIN MELT. It can be taken without water and is the preferred formulation by children
Why use MINIRIN in nocturia?
- MINIRIN reduces the amount of urine produced during the night and therefore reduces interruption to sleep caused by the need to urinate
- MINIRIN is available for the treatment of nocturia in two dosage forms: the convenient formulation MINIRIN MELT and tablets
FIRMAGON
FIRMAGON (degarelix) is a new treatment option for men with advanced hormone-dependent prostate cancer. The growth of prostate cancer is dependent on testosterone and reducing testosterone levels can cause the cancer cells to grow more slowly, stop growing and even reduce the size of the tumour. Therefore the goal of many treatments is to reduce the level of testosterone circulating in the body.
FIRMAGON has a novel mechanism of action that is different from commonly used hormonal therapies. It provides a fast and sustained suppression of testosterone for men with prostate cancer, and it offers a new alternative to traditional GnRH agonist therapy.
FIRMAGON has recently been approved in both the EU and US. It will become available in other countries during 2009 and 2010.
TESTIM*
TESTIM is a testosterone replacement treatment for men with low levels of testosterone.
TESTIM is a clear gel that delivers testosterone into the body through the skin. Once TESTIM is absorbed, it enters the bloodstream and raises testosterone to normal levels. The testosterone delivered by TESTIM is the same as the testosterone produced in the testicles.
In clinical trials, TESTIM significantly improved the key symptoms of low testosterone.
Please note that product information presented on this website is intended only as a brief summary for the visitor's convenience in relation to the activities of the Ferring Group. Not all products or indications are licensed in every country and may be subject to further local variations. For specific product information please consult the summary of product characteristics (SPC). For advice on medical issues please consult your local medical practitioner.
(*TESTIM is a registered trademark of Auxilium Pharmaceuticals, Inc. - Ferring markets TESTIM in Europe under license from Auxilium Pharmaceuticals, Inc.)